Legal Representation
Attorney
Ilene B. Tannen
USPTO Deadlines
Next Deadline
142 days remaining
NOA E-Mailed - SOU Required
Due Date
November 27, 2025
Extension Available
Until May 27, 2026
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jun 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 27, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 5, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 5, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 5, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 6, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Feb 6, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Feb 6, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 6, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Feb 6, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Feb 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 4, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 4, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 4, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jan 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 29, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Biotechnology reagents for scientific and research use, namely, RNA polymerase and RNA polymerase formulations; Reagent kits for scientific and research use comprising generic nucleic acid template, RNA polymerase and buffers; reagents for scientific or medical research use; proteins in raw material form for scientific and medical research; Reagents for scientific purposes, namely, for use in manufacturing of pharmaceuticals
Classification
International Classes
001